Gout Incidence Down With SGLT2 Inhibitors in Type 2 Diabetes
Gout incidence rate significantly reduced with SGLT2 inhibitor vs GLP-1 receptor agonist.
General Rheumatology
Rheumatoid Arthritis Drug Decreases Gut Leakiness, Study Says
Researchers have found that tofacitinib, a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, might also treat leaky gut.
Updated Guideline for the Management of Osteoarthritis Released
In addition to a panel of experts, for the first time, the guideline was developed with the help of patients, emphasizing the importance of shared decision-making.
Prevalence of Arthropathy in Children With Down Syndrome Higher Than Previously Reported
Study researchers aimed to identify undiagnosed cases of arthropathy of Down syndrome (A-DS), time to diagnosis, and clinical, laboratory and radiologic features of A-DS at diagnosis.
Gout May Up Risk for Progression of Chronic Kidney Disease
Gout more than doubles the risk for end-stage kidney disease.
Antibiotic Use Tied to Higher Risk for Rheumatoid Arthritis
Findings show a dose- or frequency-dependent association; all antibiotic classes linked to higher odds for RA.
NSAIDs Contribute to Increased CVD Risk in Osteoarthritis
Considerable proportion of increased CHF, IHD, and stroke risk mediated by NSAID use.
Biologic Treatment for Psoriasis May Reduce Coronary Inflammation
Findings indicated by perivascular fat attenuation index, as measured by coronary CT angiography.
Cancer Risks Examined in Rheumatoid Arthritis Patients
Increased incidences found for lymphoma, lung cancer (in male patients), and cervical cancer.
Anti-TNFα Agents May Increase Risk for Crohn Disease, Ulcerative Colitis
Treatment with anti-TNFα agents for conditions other than inflammatory bowel disease may increase the risk of developing Crohn disease or ulcerative colitis.
Next post in Gastroenterology Information Center
